Stay updated on Safety & Efficacy of Dupilumab in Young Children Clinical Trial
Sign up to get notified when there's something new on the Safety & Efficacy of Dupilumab in Young Children Clinical Trial page.

Latest updates to the Safety & Efficacy of Dupilumab in Young Children Clinical Trial page
- Check6 days agoChange DetectedThe page revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check13 days agoChange DetectedPublication added: a new citation is listed under Publications for Long-Term Safety and Efficacy of Dupilumab in children aged 6 months to 5 years with severe atopic dermatitis (Paediatr Drugs, 2026 Apr 2).SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check43 days agoChange DetectedPage revision updated to v3.4.3; v3.4.2 was removed.SummaryDifference0.0%

- Check71 days agoChange DetectedRevision: v3.4.2 added; Revision: v3.4.1 removed along with a government operating-status notice. These are minor site maintenance updates and do not affect the study details or how users interact with the page.SummaryDifference0.3%

- Check78 days agoChange DetectedAdded a government funding-lapse notice about potential data delays and updated the site version from v3.4.0 to v3.4.1; these are minor, non-core changes that do not affect the main study details, To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Safety & Efficacy of Dupilumab in Young Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Efficacy of Dupilumab in Young Children Clinical Trial page.